Home » Newsletters » BioWorld Science

BioWorld Science

July 5, 2006

View Archived Issues

LBH-589: new candidate for multiple myeloma

Bioheart to receive grant to develop adult stem cell therapies

Pivotal trial for Auxilium's testosterone transmucosal film in hypogonadism

Invitrogen licenses Geron's hESC related intellectual property

MedImmune steps up efforts to develop vaccines for pediatric respiratory diseases

Treatment completed in phase I/II study of Aastrom's Tissue Repair Cells

Series A financing supports Innovive pipeline development

Medivir licenses antiviral projects to Tibotec, extends HCV research collaboration

KineMed to seek new applications for discontinued Organon compound

Avanir awarded NIAID grant for human antibody to anthrax toxin

Neupro filed in Europe for advanced Parkinson's disease

SkyePharma withdraws European filing for DepoCyte

Ethics approval for phase I study of Phosphagenics' transdermal insulin product

Micardis filed in Japan for type 2 diabetic nephropathy

Review of intracranial hemorrhage reports in Aptivus clinical trials

E-6801: a new 5-HT6 agonist with procognitive properties

Ezetimibe adds to rosuvastatin efficacy in hypercholesterolemic patients

Phase II studies show antitumor activity of panitumumab in metastatic colorectal cancer

Snapshots of new results with sunitinib in gastrointestinal stromal tumors

Study finds no resistance mutations with bevirimat in HIV patients

MD-0727 safe in healthy volunteers

CoFactor activity in colorectal cancer and infusion pharmacokinetics reported

THR-0921 active in arthritis model

Cardioprotective effects of a novel NHE-1 inhibitor

European CHMP hands down positive opinion for Exjade

New DatSCAN indication recommended for approval in Europe

Preclinical pharmacology and cardiovascular safety of COX-2 inhibitor CS-706 reported

Downregulation of Rho-GTPase activity may explain KJ-0530's neuroprotective effects

Recent patents cover therapeutics for Alzheimer's disease

Recent Roche and Lilly patents impart new agents for obesity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...